Healthtech Startups

Maya AI is a conversational AI platform that automates workflows and manages customer conversations across multiple channels, connecting with CRMs, ATS, ERPs and other tools via 200+ integrations. It serves teams in HR and recruitment, customer support, and sales and retention, and offers products including Maya Studio (an RPA workflow builder) and Maya Chat.

4 investors

MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.

4 investors

Mealogic provides an end-to-end commerce platform that lets businesses launch and run personalized, chef-crafted meal programs, combining e-commerce technology, a national chef network, and nationwide cold-chain delivery. It serves partner organizations offering nutrition-led, dietitian-approved meal programs to their communities across the United States.

4 investors

MedCheck aggregates real-world clinical data from healthcare professionals in emerging markets through a cloud-based platform to enable data-driven decision-making. The company connects physicians, medical organizations, NGOs, and pharmaceutical firms to improve healthcare outcomes via electronic medical records, clinical study portals, and data analytics tools.

4 investors

Medfin helps patients in India access surgical care by connecting them with a network of doctors and hospitals, managing health insurance processing, and offering no-cost EMI financing for procedures. It focuses on modern, minimally invasive surgical procedures aimed at faster recovery and shorter hospital stays.

4 investors

Medfin provides an AI-powered analytics platform that automatically aggregates financial and operational data from dental practices to surface key metrics and actionable recommendations. The platform uses AI models to help practice owners optimize profitability, utilization, and operational efficiency through real-time alerts and performance benchmarking.

4 investors

MediShout develops an operational efficiency platform for hospitals, integrating supplier and helpdesk systems to reduce delays and improve patient care. The company serves NHS and private hospital groups across the UK.

4 investors

Medo developed an FDA-cleared cloud platform that segmented ultrasound scans into three-dimensional anatomical views and returned findings in seconds. The interface was built so that operators without specialist sonography training could identify a range of common and urgent conditions. Exo acquired the company in 2022.

4 investors

Medoma provides technology to support hospital-at-home care, enabling hospital-level treatment for high-acuity patients to be delivered in patients' homes. The company operates a digi-physical Hospital at Home care model in Sweden.

4 investors

4 investors

Mentavi Health provides clinician-reviewed online diagnostic evaluations that screen for up to 29 mental health conditions, including ADHD, anxiety, depression, and OCD, with results reviewed by licensed doctorate-level psychologists. It serves patients directly and partners with health systems, primary care providers, higher-education institutions, and employers across the United States.

4 investors

Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration. The company operates in the biotechnology and drug development space.

4 investors

Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data. It serves biopharma, public health, consumer wellness, agriculture, and academic research clients across discovery, clinical, and translational studies.

4 investors

Miach Orthopaedics develops implants that help the body restore its own connective tissue, with an initial focus on treating ACL tears. Its lead product is the BEAR Implant for bridge-enhanced ACL restoration, positioned in the orthopedic medical device field.

4 investors

Micron Agritech develops portable pen-side diagnostic devices for animal health testing, enabling rapid diagnostics for farmers and veterinarians. The Irish company combines software, hardware, and veterinary science to provide digital solutions for the livestock sector.

4 investors

MIMOSA Diagnostics develops medical devices and technology to improve healthcare equity through diagnostic solutions. The company focuses on skin and wound healing diagnostics with a team led by experienced medical device engineers and healthcare professionals.

4 investors

MindRight Health provides culturally affirming mental health support through a community-based platform and network of peer supporters. The company serves individuals seeking accessible mental health care outside traditional systems.

4 investors

Minze Health develops solutions for diagnosing and managing lower urinary tract symptoms (LUTS), such as those caused by benign prostatic hyperplasia (BPH) or overactive bladder (OAB). The company targets the large population of adults affected by urinary conditions in the U.S. and EU.

4 investors

Mirador discovers and develops precision medicines for immune-mediated and immuno-fibrotic diseases using a target-patient matching approach. The company targets therapeutics to improve treatment efficacy beyond current standards in immunology and fibrotic conditions.

4 investors

MitoRx develops first-in-class, targeted small-molecule therapies that restore mitochondrial health to treat people with high-risk, metabolically unhealthy obesity and related cardiometabolic diseases. Its lead asset, MTRX31, aims to rebalance carbohydrate and fat oxidation to deliver fat-specific weight loss while preserving lean mass.

4 investors

4 investors

Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.

4 investors

Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS. It serves clinicians and patients, aiming to reduce reliance on in-clinic evaluations for conditions like ALS.

4 investors

Modern Fertility provides at-home laboratory tests that measure reproductive health markers, enabling women to access fertility information outside of clinical settings. The company targets women seeking early insight into their reproductive status to inform long-term family planning decisions.

4 investors